Literature DB >> 2354580

SPECT imaging with Tl-201 and Ga-67 in myocardial sarcoidosis.

C Kurata1, K Sakata, T Taguchi, Y Fukumoto, H Miyata, S Aoshima, N Yamazaki.   

Abstract

Two patients with myocardial sarcoidosis are presented, both of whom underwent SPECT imaging with Tl-201 and Ga-67. The first had Ga-67 myocardial uptake with a Tl-201 defect, which disappeared with corticosteroid therapy. The second had multiple Tl-201 defects without Ga-67 uptake, which persisted despite corticosteroid therapy. Therefore, the combination of Tl-201 and Ga-67 imaging may be useful for recognizing myocardial sarcoidosis and for predicting the response to corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2354580     DOI: 10.1097/00003072-199006000-00009

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

1.  Scintigraphic demonstration of myocardial sarcoidosis: the added value of single-photon emission computed tomography.

Authors:  P C Barneveld; C van Leeuwen; J W van Isselt
Journal:  J Nucl Cardiol       Date:  1997 May-Jun       Impact factor: 5.952

2.  Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia.

Authors:  Hideki Futamatsu; Jun-ichi Suzuki; Susumu Adachi; Hiroyuki Okada; Kenichiro Otomo; Takahiro Ohara; Yuji Hashimoto; Tsunekazu Kakuta; Yoshito Iesaka; Hiroaki Yamaguchi; Harumizu Sakurada; Akira Sato; Tohru Obayashi; Akihiro Niwa; Kenzo Hirao; Mitsuaki Isobe
Journal:  Int J Cardiovasc Imaging       Date:  2006-03-14       Impact factor: 2.357

Review 3.  Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations.

Authors:  M Sekiguchi; Y Yazaki; M Isobe; M Hiroe
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 4.  Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment.

Authors:  Joseph P Lynch; Jennifer Hwang; Jason Bradfield; Michael Fishbein; Kalyanam Shivkumar; Roderick Tung
Journal:  Semin Respir Crit Care Med       Date:  2014-07-09       Impact factor: 3.119

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.